Business Standard

Sell Aurobindo Pharma, buy Granules India, says Anand Rathi Research

Nifty outlook and top trading ideas by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Research

Markets, Buy, Sell, Stocks, Shares
Premium

Photo: Shutterstock.com

Jay Anand Thakkar Mumbai
Nifty outlook and top trading ideas by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Research:

NIFTY - BUY 
Target: 10,290 
Stop Loss: Rs 10,090

Nifty closed in the negative territory in the last trading session however the Index has recovered well from the lower end which indicates that the probability of a reversal from these levels is quite likely. On the lower side, 10,090 is an immediate support, hence with that as a stop loss one can buy for the target of 10,290 levels

AUROBINDO PHARMA - SELL 
Target: Rs 695 
Stop Loss: Rs 745

The stock has broken the symmetrical triangular pattern

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in